BioCentury
ARTICLE | Financial News

TG raises $50M in follow-on

March 9, 2017 8:16 PM UTC

TG Therapeutics Inc. (NASDAQ:TGTX) added $1.65 (16%) to $11.80 on Thursday after it raised $50 million through the sale of 5.1 million shares at $9.75 in a follow-on underwritten by Jefferies, SunTrust, Ladenburg Thalmann, H.C. Wainwright, Aegis Capital, Roth Capital Partners and OPN Capital Markets.

The price is a 4% discount to TG's close of $10.15 on Wednesday, when it proposed the offering after market hours...

BCIQ Company Profiles

TG Therapeutics Inc.